Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 20INDUSTRY 10OTHER_GOV 2NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 19Thoracic 5Breast 2Sarcoma 1NET 1Endocrine 1

Conditions

Breast Neoplasms 1Breast Cancer Metastatic 1

Interventions

Tamoxifen 10Capecitabine 10Trastuzumab 9Docetaxel 9pyrotinib 7Exercise 7Control Groups 7Vinorelbine 6Paclitaxel 6Letrozole 6Gemcitabine 6Cyclophosphamide 6Carboplatin 6exemestane 5Indocyanine Green 5Anastrozole 5pertuzumab 4dalpiciclib 4Injections 4Fulvestrant 4Doxorubicin 4Surgical Procedures, Operative 3Standard of Care 3Radiotherapy 3Radiation 3Mammography 3Epirubicin 3Drug Therapy 3Cisplatin 3Bevacizumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Irinotecan × Breast × Clear all
NCT01501669 2012-07-18

PROCEED

National Cancer Center, Korea

Phase 3 Unknown
222 enrolled
Breast

Breast Neoplasms

NCT00532714 2011-12-30

Phase II Study of Irinotecan/Capecitabine in Patients With Antracycline/Taxane Pretreated MBC

National Cancer Center, Korea

Phase 2 Completed
36 enrolled
Breast

Breast Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡